Discovery opens new avenues for designing drugs to combat drug-resistant malaria

For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart.


Click here for original story, Discovery opens new avenues for designing drugs to combat drug-resistant malaria


Source: Phys.org